Page last updated: 2024-11-04

sulfadiazine and Hematologic Diseases

sulfadiazine has been researched along with Hematologic Diseases in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research Excerpts

ExcerptRelevanceReference
" Dosage must be adjusted to the results of blood counts."2.38[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients]. ( Leport, C; Niyongabo, T; Vildé, JL, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Niyongabo, T1
Leport, C1
Vildé, JL1

Reviews

1 review available for sulfadiazine and Hematologic Diseases

ArticleYear
[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].
    Presse medicale (Paris, France : 1983), 1991, Oct-26, Volume: 20, Issue:34

    Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Folic Acid; Hematologic Diseases; Hum

1991